galactose has been researched along with Urinary Tract Infections in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (55.56) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Anbazhagan, V; Arunachalam, J; Bala Subramaniyan, S; Senthilnathan, R | 1 |
Hultgren, SJ; Janetka, JW; Kalas, V; Klein, R; Maddirala, AR; Pinkner, JS | 1 |
Conover, MS; Dodson, KW; Hadjifrangiskou, M; Hibbing, ME; Hultgren, SJ; Palermo, JJ | 1 |
Glockshuber, R; Kong, XP; Min, G; Mo, WJ; Neubert, TA; Sebbel, P; Sun, TT; Wu, XR; Zhou, G | 1 |
Cläeson, I; de Man, P; Jodal, U; Johanson, IM; Svanborg Edén, C | 1 |
de Man, P; Enerbäck, S; Larsson, AC; Leffler, H; Lundell, A; Nilsson, B; Svanborg-Edén, C | 1 |
Braude, AI; Ryan, JL; Turck, M | 1 |
Taylor, PW | 1 |
Engwall, C; Slifkin, M | 1 |
9 other study(ies) available for galactose and Urinary Tract Infections
Article | Year |
---|---|
Revealing the Significance of the Glycan Binding Property of
Topics: Anti-Bacterial Agents; Biofilms; Butea; Escherichia coli Infections; Galactose; Humans; Metal Nanoparticles; Molecular Docking Simulation; Plant Lectins; Silver; Urinary Tract Infections; Uropathogenic Escherichia coli | 2020 |
Biphenyl Gal and GalNAc FmlH Lectin Antagonists of Uropathogenic E. coli (UPEC): Optimization through Iterative Rational Drug Design.
Topics: Adhesins, Escherichia coli; Administration, Oral; Animals; Biphenyl Compounds; Drug Design; Galactosamine; Galactose; Half-Life; Humans; Mice; Microsomes, Liver; Rats; Structure-Activity Relationship; Urinary Tract Infections; Uropathogenic Escherichia coli | 2019 |
Metabolic Requirements of Escherichia coli in Intracellular Bacterial Communities during Urinary Tract Infection Pathogenesis.
Topics: Animals; Biofilms; Carbon; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Galactose; Humans; Mice; Mice, Inbred C3H; Urinary Tract; Urinary Tract Infections; Uropathogenic Escherichia coli; Virulence | 2016 |
Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence from in vitro FimH binding.
Topics: Adhesins, Bacterial; Adhesins, Escherichia coli; Amino Acid Sequence; Animals; Bacterial Outer Membrane Proteins; Bacterial Proteins; Cattle; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fimbriae Proteins; Galactose; Glycosylation; Hydrogen-Ion Concentration; Immunohistochemistry; Lectins; Mannose; Mass Spectrometry; Membrane Glycoproteins; Mice; Molecular Sequence Data; Protein Binding; Recombinant Fusion Proteins; Sequence Alignment; Tetraspanins; Urinary Tract Infections; Uroplakin Ia; Urothelium | 2001 |
Bacterial attachment as a predictor of renal abnormalities in boys with urinary tract infection.
Topics: Adolescent; Bacterial Adhesion; Child; Child, Preschool; Cicatrix; Cystitis; Escherichia coli; Galactose; Humans; Infant; Infant, Newborn; Kidney Diseases; Male; Prospective Studies; Pyelonephritis; Risk Factors; Urinary Tract Infections; Urography | 1989 |
Binding to galactose alpha 1----4galactose beta-containing receptors as potential diagnostic tool in urinary tract infection.
Topics: Adhesins, Escherichia coli; Bacterial Proteins; Child; Cystitis; Escherichia coli; Escherichia coli Infections; Female; Galactose; Globosides; Hemagglutination Tests; Humans; Latex Fixation Tests; Pyelonephritis; Receptors, Cell Surface; Receptors, Immunologic; Urinary Tract Infections | 1987 |
Galactose-deficient endotoxin from urinary Escherichia coli.
Topics: Endotoxins; Escherichia coli; Escherichia coli Infections; Galactose; Humans; Lipopolysaccharides; Polysaccharides, Bacterial; Urinary Tract Infections | 1973 |
Immunochemical investigations on lipopolysaccharides and acidic polysaccharides from serum-sensitive and serum-resistant strains of Escherichia coli isolated from urinary-tract infections.
Topics: Blood Bactericidal Activity; Escherichia coli; Hemagglutination Inhibition Tests; Heptoses; Hexosamines; Hexoses; Hexuronic Acids; Humans; Lipopolysaccharides; Lysogeny; Neuraminic Acids; Polysaccharides, Bacterial; Species Specificity; Sugar Acids; Urinary Tract Infections | 1976 |
The clinical significance of Citrobacter intermedium.
Topics: Anti-Bacterial Agents; Cellulitis; Chemical Phenomena; Chemistry; Citrates; Disaccharides; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hexoses; Humans; Male; Neoplasms; Nitrates; Sepsis; Urinary Tract Infections | 1969 |